Prostate News Archive
09-Sep-2008
Bostwick wins approval to initiate Phase I/II prostate cancer trial (Pharmaceutical Business Review)
Bostwick Therapeutics has received clearance from the FDA and the Institutional Review Board of Community Memorial Hospital, Ventura, California, to initiate the Critical trial, a clinical trial examining the potential of a novel combination of cryoablation and intra-tumoral injection of virgin dendritic cells to treat men with metastatic androgen-independent prostate cancer. CCU president urges prostate testing (WPDE-TV Myrtle Beach - Florence)
Story By Joel Allen Posted on Monday, September 08, 2008 at 5:46 p.m. Coastal Carolina University president Dr. David DeCenzo is back at work now, after surgery last month to have his prostate removed. Brad Garrett Promotes Cancer Research by Getting a Prostate Exam On-Air (HispanicBusiness.com)
Brad Garrett of Everybody Loves Raymond received a prostate exam on-air last Friday to show men that such a procedure doesn't have to be embarrassing, and in fact, can save lives. Painkillers Appear To Lower Prostate Cancer Marker (Medical News Today)
New research from the US found that men who regularly took common painkillers like aspirin and ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) had lower circulating levels of PSA (prostate-specific antigen), the biomarker that doctors use to assess whether a man is at risk of prostate cancer. Study: Aspirin, Ibuprofen May Hinder Prostate Exams (Fox News)
Common over-the-counter pain relievers may interfere with the detection of prostate cancer, according to a study published in the Oct. 15 issue of the journal Cancer.
Back to Prostate News Archive
